2020-07-15 PDB 2020-07-15 公開エントリー2件を追加
[ブログ記事の字数制限のため一覧を分割]
 新型コロナウイルスのPDB公開構造一覧: その4(本記事); - その3; - その2; - その1
[参考: PDBjの新型コロナウイルスの構造情報]

#

ID

Title

Release Date

35

6XOA

The crystal structure of 3CL MainPro of SARS-CoV-2 with C145S mutation (#246XKFの登録者共通)

07/15/2020

34

6XKL

SARS-CoV-2 HexaPro S One RBD up [Structure-based Design of Prefusion-stabilized SARS-CoV-2 Spikes]

07/15/2020
bioRixv 20200530

33

6XC2

Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC12.1

07/08/2020
bioRxiv 20200906

32

6XC3

Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CC12.1 and CR3022

07/08/2020
bioRxiv 20200906

31

6XC4

Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC12.3

07/08/2020
bioRxiv 20200906

30

6XC7

Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CC12.3 and CR3022

07/08/2020
bioRxiv 20200906

29

6ZFO

Association of two complexes of largely structurally disordered Spike ectodomain with bound EY6A Fab

07/08/2020
bioRixv 20200613

28

6ZER

Crystal structure of receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with EY6A Fab

06/24/2020
bioRixv 20200613

27

6ZCZ

Crystal structure of receptor binding domain of SARS-CoV-2 Spike glycoprotein in ternary complex with EY6A Fab and a nanobody

06/24/2020
bioRixv 20200613

26

6XMK

1.70 A resolution structure of SARS-CoV-2 3CL protease in complex with inhibitor 7j

07/08/2020

25

6XHM

Covalent complex of SARS-CoV-2 main protease with N-[(2S)-1-({(2S,3S)-3,4-dihydroxy-1-[(3S)-2-oxopyrrolidin-3-yl]butan-2-yl}amino)-4-methyl-1-oxopentan-2-yl]-4-methoxy-1H-indole-2-carboxamide [The Discovery of Ketone-Based Covalent Inhibitors of Coronavirus 3CL Proteases for the Potential Therapeutic Treatment of COVID-19]

07/08/2020

24

6XKF

The crystal structure of 3CL MainPro of SARS-CoV-2 with oxidized Cys145 (Sulfenic acid cysteine)

07/08/2020

23

6XKH

THE 1.28A CRYSTAL STRUCTURE OF 3CL MAINPRO OF SARS-COV-2 WITH OXIDIZED C145 (sulfinic acid cysteine)

07/08/2020

22

6XKM

Room Temperature Structure of SARS-CoV-2 NSP10/NSP16 Methyltransferase in a Complex with SAM Determined by Fixed-Target Serial Crystallography

07/08/2020

21

6XHU

Room temperature X-ray crystallography reveals oxidation and reactivity of cysteine residues in SARS-CoV-2 3CL Mpro: Insights for enzyme mechanism and drug design

07/01/2020

20

6ZGG

Furin Cleaved Spike Protein of SARS-CoV-2 with One RBD Erect

07/01/2020

19

6ZGH
6ZGI
6ZGE

Furin Cleaved Spike Protein of SARS-CoV-2 in Intermediate Conformation
Furin Cleaved Spike Protein of SARS-CoV-2 in Closed Conformation
Uncleavable Spike Protein of SARS-CoV-2 in Closed Conformation

07/01/2020
07/01/2020
07/01/2020
Research Square 2020-05-20 

18

7C2L

S protein of SARS-CoV-2 in complex bound with 4A8

07/01/2020
crisp_bio 2020-07-05
Science 2020-06-22

17

6XE1

Structure of SARS-CoV-2 spike protein receptor binding domain in complex with a potent neutralizing antibody, CV30 Fab

07/01/2020
bioRxiv 2020-06-12

16

6ZDH

SARS-CoV-2 Spike glycoprotein in complex with a neutralizing antibody EY6A Fab

07/01/2020
bioRxiv 2020-06-13

15

6ZCO

Crystal Structure of C-terminal Dimerization Domain of Nucleocapsid Phosphoprotein from SARS-CoV-2, crystal form II

07/01/2020

14

6Z97
6YM0

6YLA
6YOR

Structure of the prefusion SARS-CoV-2 spike glycoprotein
SARS-CoV-2 RBD in complex with CR3022 Fab (crystal form 1)
SARS-CoV-2 RDB in complex with CR3022 Fab (crystal form 2)
Structure of the SARS-CoV-2 spike S1 protein in complex with CR3022 Fab

07/01/2020
04/29/2020
04/15/2020
04/29/2020
Cell Host Microbe 2020-06-19

13

6XCM
6XCN

SARS-CoV-2 S in complex with the C105 neutralizing antibody Fab fragment (state 1)
SARS-CoV-2 S in complex with the C105 neutralizing antibody Fab fragment (state 2)

07/01/2020
07/01/2020
Cell 2020-06-24

12

6XIP

The 1.5 A Crystal Structure of the Co-factor Complex of NSP7 and the C-terminal Domain of NSP8 from SARS CoV-2

07/01/2020

11

7C8U

The crystal structure of COVID-19 main protease in complex with GC376

06/24/2020

10

7CAN

Structure of sybody MR17-K99Y in complex with the SARS-CoV-2 S Receptor-binding domain (RBD) [Potent synthetic nanobodies against SARS-CoV-2 and molecular basis for neutratlization]

06/24/2020

9

7C8W

Structure of sybody MR17 in complex with the SARS-CoV-2 S receptor-binding domain (RBD)

06/24/2020

8

7C8V

Structure of sybody SR4 in complex with the SARS-CoV-2 S Receptor Binding domain (RBD)

06/24/2020

7

6XFN

Crystal structure of the SARS-CoV-2 (COVID-19) main protease in complex with UAW243

06/24/2020

6

6ZCT

Nonstructural protein 10 (nsp10) from SARS CoV-2

06/24/2020

5

6XG2

The 1.28A crystal structure of 3CL MainPro of SARS-CoV-2 with oxidized Cys145.

06/24/2020

4

6ZER

Crystal structure of receptor binding domain of SARS-CoV-2 Spike glycoprotein in complex with EY6A Fab

06/24/2020

3

6XDG

Complex of SARS-CoV-2 receptor binding domain with the Fab fragments of two neutralizing antibodies [Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail.]

06/24/2020
Science

2

6XG3

The crystal structure of Papain-Like Protease of SARS CoV-2 , C111S mutant, at room temperature

06/24/2020

1

6ZCZ

Crystal structure of receptor binding domain of SARS-CoV-2 Spike glycoprotein in ternary complex with EY6A Fab and a nanobody.

06/24/2020


2020-07-08までの更新履歴
2020-07-08 PDB 2020-07-08 公開エントリーを追加
 #27と#28は2020-06-24公開であるが#29と同じbioRxiv 2020-06-13投稿掲載構造ということで再掲。
2020-07-01 PDB 2020-07-01 公開エントリーを追加
 07-01公開エントリーについては、同一投稿または論文掲載分を1行にまとめた
 (その中に07-01より以前に公開されたエントリーも再掲)
2020-06-28 PDB2020-06-24公開11エントリーを収録